SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-052462
Filing Date
2023-10-10
Accepted
2023-10-10 12:48:53
Documents
2
Period of Report
2023-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1614
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4448
  Complete submission text file 0001209191-23-052462.txt   7415
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
Horn Howard (Reporting) CIK: 0001786335 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36276 | Film No.: 231317075